Home/Diagnostics Insights/Expert Opinion/TRAPID-AMI sub-study: Use of very low concentration of hs-TnT to rule out AMI using a single blood test

TRAPID-AMI sub-study: Use of very low concentration of hs-TnT to rule out AMI using a single blood test

Expert Opinion
Diagnostics Insights

Key Takeaways

  • Non-detectable (very low levels) of hs-Tn is associated with a low likelihood of developing a NSTEMI and has a high NPV (99%) for MI with high safety and a very few MACE events at 30 day follow up

Video transcript:

Theoretically, non-detectable troponin is associated with a very low likelihood to have a non-STEMI or to develop a non-STEMI, and following this concept, a Body investigated from the TRAPID-AMI study the concept of 0- and 1-hour testing using 3 different cut-off concentrations: one at the limit of blank, that is 3 ng/L; one at the limit of detection that is now part of the guideline recommendation 2015, at 5ng/L, and finally; at the 99th percentile value of a healthy reference population, that is 14 ng/L.

He found that with all 3 concepts, there was a very low detection rate of infarct, rendering a negative predictive value of more than 99% with a very high safety with very few MACE events at 30-day follow-up. This concept was important for a third of the TRAPID-AMI population which is a representative suspected ACS cohort.